PMDA — authorised 19 July 2021
- Marketing authorisation holder: CHUGAI PHARMACEUTICAL Co., Ltd
- Status: approved
🇯🇵 IMDEVIMAB in Japan
PMDA authorised IMDEVIMAB on 19 July 2021
Marketing authorisation
IMDEVIMAB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Japan
Frequently asked questions
Is IMDEVIMAB approved in Japan?
Yes. PMDA authorised it on 19 July 2021.
Who is the marketing authorisation holder for IMDEVIMAB in Japan?
CHUGAI PHARMACEUTICAL Co., Ltd holds the Japanese marketing authorisation.